INTERNATIONAL AIDS VACCINE INITIATIVE INC.
NEW YORK, New York
Total Received
$392.4M
Total Awards
21
State
New York
Last Updated
Mar 5, 2026
Yearly Funding Trend
$385.1M24
$7.2M25
Top 21 Awards to INTERNATIONAL AIDS VACCINE INITIATIVE INC.
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 5, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_AIDOAAA1600032_072 HIV VACCINE AND BIOMEDICAL PREVENTION RESEARCH PROJECT (HVBP) OBJECTIVE 1 & 2 | Agency for International Development Agency for International Development | 98.001 USAID FOREIGN ASSISTANCE FOR PROGRAMS OVERSEAS | NEW YORK, NY-10 | 2024 | $237,852,031 |
CONT_AWD_75A50121C00077_7505_-NONE-_-NONE- THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACC… | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | NEW YORK, NY-10 | 2024 | $95,592,504 |
CONT_AWD_HDTRA121C0005_9700_-NONE-_-NONE- ACCELERATED DEVELOPMENT OF A SARS-COV-2 VACCINE BASED ON THE LIVE VSV.G CHIMERIC VIRUS PLATFORM | Department of Defense Defense Threat Reduction Agency | — | NEW YORK, NY-10 | 2024 | $26,261,466 |
CONT_AWD_75N93022F00001_7529_75N93022D00005_7529 CGMP MANUFACTURE, FILL-FINISH, RELEASE, ANALYTICAL AND STABILITY TESTING AND STABILITY PROGRAM OF A NANOPARTICLE BASED HIV ENVELOPE VACCINE | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2024 | $8,013,603 |
ASST_NON_W81XWH1710656_097 ADVANCING A PROMISING TUBERCULOSIS VACCINE CANDIDATE: MTBVAC DE-OBLIGATE FUNDS TO CLOSE AWARD 1. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION ACT (NDAA) 2019, THE US ARMY… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | NEW YORK, NY-10 | 2025 | $6,059,848 |
CONT_AWD_75N93018F00002_7529_75N93018D00010_7529 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; MANUFACTURE OF HUMAN FLU CHALLENGE MATERIAL | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2024 | $4,062,306 |
CONT_AWD_75N93023F00001_7529_75N93018D00010_7529 CONTRACT HHSN272201800010I INTERNATIONAL AIDS VACCINE INITIATIVE; MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE I AND II CLINICAL TESTING | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2024 | $3,625,389 |
CONT_AWD_75N93021F00239_7529_HHSN272201600011I_7529 THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE… | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2024 | $2,250,744 |
CONT_AWD_75N93019F00131_7529_75N93018D00010_7529 1800010I INTERNATIONAL AIDS VACCINE INITIATIVE; OPTION 2 FY 21 $666,400 | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2024 | $1,753,724 |
CONT_AWD_75N93019F00269_7529_HHSN272201600011I_7529 PROCESS DEVELOPMENT FOR CELL CULTURE, UPSTREAM AND DOWNSTREAM PROCESS IN PRODUCTION OF HIV-1 BIOMOLECULES | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2024 | $1,707,175 |
ASST_NON_R61AI169132_075 DEVELOPMENT OF NOVEL MRNA VACCINES AGAINST MYCOBACTERIUM TUBERCULOSIS - PROJECT SUMMARY/ABSTRACT TUBERCULOSIS REMAINS ONE OF THE TOP TEN LEADING CAUSES OF DEATH WORLDWIDE (1). BAS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NY-90 | 2024 | $1,336,253 |
CONT_AWD_75N93019F00270_7529_HHSN272201600011I_7529 ANTIGEN-ADJUVANT FORMULATION AND CHARACTERIZATION STUDIES | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2024 | $978,729 |
CONT_AWD_75N93019F00132_7529_HHSN272201600011I_7529 PROCESS AND ASSAY DEVELOPMENT FOR CGMP PRODUCTION AND CHARACTERIZATION OF A VSV CANDIDATE | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2024 | $859,745 |
ASST_NON_R33AI169132_075 DEVELOPMENT OF NOVEL MRNA VACCINES AGAINST MYCOBACTERIUM TUBERCULOSIS - PROJECT SUMMARY/ABSTRACT TUBERCULOSIS REMAINS ONE OF THE TOP TEN LEADING CAUSES OF DEATH WORLDWIDE (1). BAS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | NEW YORK, NY-10 | 2025 | $700,469 |
ASST_NON_U01AI131861_075 MTBVAC PHASE 1B/2A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, SAFETY, IMMUNOGENICITY, AND DOSE-ESCALATION STUDY IN ADULTS WITH AND WITHOUT LATENT TUBERCULOSIS INFECTION IN SOUTH… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | — | 2024 | $556,495 |
CONT_AWD_75N93019F00131_7529_HHSN272201600011I_7529 COORDINATION AND TECHNICAL SUPPORT | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2024 | $299,063 |
CONT_AWD_75N93020F00001_7529_HHSN272201600011I_7529 COORDINATION AND TECHNICAL SUPPORT | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2025 | $256,138 |
CONT_AWD_75N93021F00240_7529_HHSN272201600011I_7529 COORDINATION AND TECHNICAL SUPPORT | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2025 | $177,790 |
CONT_AWD_75N93020F00001_7529_75N93018D00010_7529 EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI TO FULLY TERMINATE THIS CONTRACT FOR CONVENIENCE, EFFECTIVE A… | Department of Health and Human Services National Institutes of Health | — | NEW YORK, NY-10 | 2025 | $20,264 |
CONT_IDV_75N93018D00010_7529 EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI TO FULLY TERMINATE THIS CONTRACT FOR CONVENIENCE, EFFECTIVE A… | Department of Health and Human Services National Institutes of Health | — | — | 2025 | $0 |
CONT_IDV_HHSN272201600011I_7529 NIAID PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES | Department of Health and Human Services National Institutes of Health | — | — | 2025 | $0 |
Top 21 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→Source: USAspending.gov · All Recipients · New York